400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2026-01-21
口服小分子心肌肌球蛋白抑制剂研发商
医药研发/制造
化学&生物药
RTW Investments;
RTW Investments;
SR One;
SR One;
TCG X;
RA Capital;
HBM Healthcare;
Symbiosis;
Adage Capital Partners LP;
Invus;
SilverArc Capital;
横店资本
药市场透视2026-06-16
罕见病信息网2026-06-15
药筛2026-06-15
求实药社2026-06-15
GLP1减重宝典2026-06-15
亚太易和2026-06-15
synbio深波2026-06-15
细胞与基因治疗领域2026-06-15
GMP行业药文2026-06-15
生物技术小编2026-06-15